{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:31:46Z","timestamp":1794335506644,"version":"4.9.0"},"reference-count":59,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Taishan Scholars Program of Shandong Province","award":["tsqn202408353"],"award-info":[{"award-number":["tsqn202408353"]}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2022J05051"],"award-info":[{"award-number":["2022J05051"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["GZB20240404"],"award-info":[{"award-number":["GZB20240404"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030063"],"award-info":[{"award-number":["82030063"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202597"],"award-info":[{"award-number":["82202597"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2025,6,26]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The elimination of HBV covalently closed circular DNA (cccDNA) remains a critical hurdle for chronic hepatitis B (CHB) management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>In this investigation, we examined the efficacy of glycine administration and its potential enhancement in interferon-\u03b1 (IFN-\u03b1) antiviral efficacy to stimulate hepatocyte proliferation to mitigate cccDNA levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>The study cohort comprised 89 healthy individuals and 496 HBV-infected patients, with subgroups of 30 and 42 participants receiving randomised nucleos(t)ide analogue (NA) and PegIFN-\u03b1 treatments, respectively. Glycine concentrations were quantified via liquid chromatography\u2012tandem mass spectrometry, and its diagnostic potential was assessed via receiver operating characteristic curve analysis. The therapeutic impact of glycine was evaluated in various HBV-infected cell lines and murine models via various methodologies including transcriptomic sequencing, metabolomics sequencing, flow cytometry, immunofluorescence and in situ hybridisation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Elevated serum glycine levels with a robust positive correlation with serum alanine aminotransferase levels (R=0.7650) were observed in HBV-infected patients relative to healthy controls. The area under the curve for differentiating patients with HBeAg-expressing CHB from healthy controls was 0.9701. Glycine supplementation diminished HBV cccDNA levels by approximately 50% by promoting hepatocyte proliferation. Glycine is metabolised into a one-carbon unit, activating mTORC1 signalling via glycine transporter-1. Furthermore, glycine ameliorates hepatic inflammation by inhibiting the nuclear factor-kappa B signalling pathway through glycine receptors. Combination therapy with IFN-\u03b1 effectively suppressed HBV replication, achieving a 60% reduction in HBsAg levels and sustained viral suppression in mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Glycine has the potential to reduce HBV cccDNA levels by stimulating hepatocyte proliferation. The phased administration of glycine and IFN-\u03b1 significantly enhances its therapeutic efficacy. These findings suggest a novel and promising strategy for the treatment of CHB.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2025-334813","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T21:40:30Z","timestamp":1752270030000},"page":"2035-2049","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Therapeutic inhibition of HBsAg and HBV cccDNA through a novel phased combination treatment: glycine and interferon-\u03b1"],"prefix":"10.1136","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8680-3159","authenticated-orcid":false,"given":"Caorui","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China"},{"name":"Department of Laboratory Medicine, Fujian Key Laboratory of Laboratory Medicine, Fujian Clinical Research Center for Laboratory Medicine of Immunology, Gene Diagnosis Research Center, National Reginal Medical Center, Binhai Campus of the First Affiliated Hospital, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fujian Key Laboratory of Laboratory Medicine, Fujian Clinical Research Center for Laboratory Medicine of Immunology, Gene Diagnosis Research Center, National Reginal Medical Center, Binhai Campus of the First Affiliated Hospital, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9149-5940","authenticated-orcid":false,"given":"Ning","family":"Ran","sequence":"additional","affiliation":[{"name":"Institute of Medical Sciences, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China"},{"name":"Shandong University Orthopedic Research Center, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjie","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fujian Key Laboratory of Laboratory Medicine, Fujian Clinical Research Center for Laboratory Medicine of Immunology, Gene Diagnosis Research Center, National Reginal Medical Center, Binhai Campus of the First Affiliated Hospital, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fujian Key Laboratory of Laboratory Medicine, Fujian Clinical Research Center for Laboratory Medicine of Immunology, Gene Diagnosis Research Center, National Reginal Medical Center, Binhai Campus of the First Affiliated Hospital, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosang","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fujian Key Laboratory of Laboratory Medicine, Fujian Clinical Research Center for Laboratory Medicine of Immunology, Gene Diagnosis Research Center, National Reginal Medical Center, Binhai Campus of the First Affiliated Hospital, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Xun","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fujian Key Laboratory of Laboratory Medicine, Fujian Clinical Research Center for Laboratory Medicine of Immunology, Gene Diagnosis Research Center, National Reginal Medical Center, Binhai Campus of the First Affiliated Hospital, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fujian Key Laboratory of Laboratory Medicine, Fujian Clinical Research Center for Laboratory Medicine of Immunology, Gene Diagnosis Research Center, National Reginal Medical Center, Binhai Campus of the First Affiliated Hospital, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fujian Key Laboratory of Laboratory Medicine, Fujian Clinical Research Center for Laboratory Medicine of Immunology, Gene Diagnosis Research Center, National Reginal Medical Center, Binhai Campus of the First Affiliated Hospital, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Kong","sequence":"additional","affiliation":[{"name":"Shandong University Orthopedic Research Center, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqing","family":"Feng","sequence":"additional","affiliation":[{"name":"Shandong University Orthopedic Research Center, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiting","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qishui","family":"Ou","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fujian Key Laboratory of Laboratory Medicine, Fujian Clinical Research Center for Laboratory Medicine of Immunology, Gene Diagnosis Research Center, National Reginal Medical Center, Binhai Campus of the First Affiliated Hospital, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"2025120523162485000_74.12.2035.1","unstructured":"World Health Organization . Global hepatitis report 2024 action for access in low- and middle-income countries. World Health Organization, 2024."},{"key":"2025120523162485000_74.12.2035.2","unstructured":"WHO . Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. World Health Organization, 2024."},{"key":"2025120523162485000_74.12.2035.3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S2468-1253(22)00386-7","article-title":"Global reporting of progress towards elimination of hepatitis B and hepatitis C","volume":"8","author":"Cui","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025120523162485000_74.12.2035.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-022-00649-z"},{"key":"2025120523162485000_74.12.2035.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.05.008"},{"key":"2025120523162485000_74.12.2035.6","doi-asserted-by":"publisher","DOI":"10.1126\/science.1243462"},{"key":"2025120523162485000_74.12.2035.7","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309809"},{"key":"2025120523162485000_74.12.2035.8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection","volume":"479\u2013480","author":"Seeger","year":"2015","journal-title":"Virology (Auckl)"},{"key":"2025120523162485000_74.12.2035.9","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2468-1253(19)30119-0","article-title":"A global scientific strategy to cure hepatitis B","volume":"4","author":"Revill","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025120523162485000_74.12.2035.10","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32314"},{"key":"2025120523162485000_74.12.2035.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.05.022"},{"key":"2025120523162485000_74.12.2035.12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0908365106"},{"key":"2025120523162485000_74.12.2035.13","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2014.64","article-title":"Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance","volume":"3","author":"Yang","year":"2014","journal-title":"Emerg Microbes Infect"},{"key":"2025120523162485000_74.12.2035.14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jconrel.2024.08.019","article-title":"Enhanced delivery of CRISPR\/Cas9 system based on biomimetic nanoparticles for hepatitis B virus therapy","volume":"374","author":"Wu","year":"2024","journal-title":"J Control Release"},{"key":"2025120523162485000_74.12.2035.15","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312162"},{"key":"2025120523162485000_74.12.2035.16","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.apsb.2014.05.002","article-title":"Therapeutic strategies for a functional cure of chronic hepatitis B virus infection","volume":"4","author":"Chang","year":"2014","journal-title":"Acta Pharm Sin B"},{"key":"2025120523162485000_74.12.2035.17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23611"},{"key":"2025120523162485000_74.12.2035.18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001082","article-title":"Generation of covalently closed circular DNA of hepatitis B viruses via intracellular recycling is regulated in a virus specific manner","volume":"6","author":"K\u00f6ck","year":"2010","journal-title":"PLoS Pathog"},{"key":"2025120523162485000_74.12.2035.19","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.1093\/cid\/ciw023","article-title":"Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential","volume":"62 Suppl 4","author":"Dandri","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2025120523162485000_74.12.2035.20","doi-asserted-by":"publisher","DOI":"10.1007\/s000180050030"},{"key":"2025120523162485000_74.12.2035.21","doi-asserted-by":"publisher","DOI":"10.1097\/00075197-200303000-00013"},{"key":"2025120523162485000_74.12.2035.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.03.003"},{"key":"2025120523162485000_74.12.2035.23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz2841","article-title":"Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome","volume":"12","author":"Rom","year":"2020","journal-title":"Sci Transl Med"},{"key":"2025120523162485000_74.12.2035.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2023.03.013"},{"key":"2025120523162485000_74.12.2035.25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cmet.2023.12.013","article-title":"Serine synthesis via reversed SHMT2 activity drives glycine depletion and acetaminophen hepatotoxicity in MASLD","volume":"36","author":"Ghrayeb","year":"2024","journal-title":"Cell Metab"},{"key":"2025120523162485000_74.12.2035.26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jphs.2018.08.005","article-title":"Glycine mitigates renal oxidative stress by suppressing Nox4 expression in rats with streptozotocin-induced diabetes","volume":"137","author":"Wang","year":"2018","journal-title":"J Pharmacol Sci"},{"key":"2025120523162485000_74.12.2035.27","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00726-019-02722-5","article-title":"Glycine protects partial liver grafts from Kupfer cell-dependent ischemia\u2013reperfusion injury without negative efect on regeneration","volume":"51","author":"Al-Saeedi","year":"2019","journal-title":"Amino Acids"},{"key":"2025120523162485000_74.12.2035.28","first-page":"G924","article-title":"Intravenous glycine improves survival in rat liver transplantation","volume":"276","author":"Schemmer","year":"1999","journal-title":"Am J Physiol"},{"key":"2025120523162485000_74.12.2035.29","first-page":"741","article-title":"Glycine in Carolina rinse solution reduces reperfusion injury, improves graft function, and increases graft survival after rat liver transplantation","volume":"27","author":"Bachmann","year":"1995","journal-title":"Transplant Proc"},{"key":"2025120523162485000_74.12.2035.30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/08941930903469466","article-title":"Glycine pretreatment ameliorates liver injury after partial hepatectomy in the rat","volume":"23","author":"Benko","year":"2010","journal-title":"J Invest Surg"},{"key":"2025120523162485000_74.12.2035.31","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"3","author":"Yan","year":"2012","journal-title":"Elife"},{"key":"2025120523162485000_74.12.2035.32","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/22221751.2019.1625728","article-title":"Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection","volume":"8","author":"Yan","year":"2019","journal-title":"Emerg Microbes Infect"},{"key":"2025120523162485000_74.12.2035.33","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-393934"},{"key":"2025120523162485000_74.12.2035.34","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401677"},{"key":"2025120523162485000_74.12.2035.35","doi-asserted-by":"publisher","DOI":"10.2174\/092986706776360932"},{"key":"2025120523162485000_74.12.2035.36","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2012.212"},{"key":"2025120523162485000_74.12.2035.37","doi-asserted-by":"publisher","DOI":"10.3945\/jn.109.113670"},{"key":"2025120523162485000_74.12.2035.38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1820161116"},{"key":"2025120523162485000_74.12.2035.39","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.138"},{"key":"2025120523162485000_74.12.2035.40","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1161\/CIRCRESAHA.119.316090","article-title":"NAADP\/SERCA3-Dependent Ca2+ Stores Pathway Specifically Controls Early Autocrine ADP Secretion Potentiating Platelet Activation","volume":"127","author":"Feng","year":"2020","journal-title":"Circ Res"},{"key":"2025120523162485000_74.12.2035.41","doi-asserted-by":"crossref","unstructured":"Ebrahim S , Ballesteros A , Zheng WS , et al . Transmembrane channel-like 4 and 5 proteins at microvillar tips are potential ion channels and lipid scramblases. bioRxiv [Preprint] 2024. doi:10.1101\/2024.08.22.609173","DOI":"10.1101\/2024.08.22.609173"},{"key":"2025120523162485000_74.12.2035.42","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00197.2002"},{"key":"2025120523162485000_74.12.2035.43","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/hep.29213","article-title":"A potent hepatitis B surface antigen response in subjects with inactive hepatitis B surface antigen carrier treated with pegylated-interferon alpha","volume":"66","author":"Cao","year":"2017","journal-title":"Hepatology"},{"key":"2025120523162485000_74.12.2035.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.024"},{"key":"2025120523162485000_74.12.2035.45","unstructured":"Li H , Yan L , Shi Y , et al . Hepatitis infection B virus: molecular virology to antiviral drugs. 2020."},{"key":"2025120523162485000_74.12.2035.46","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i12.3527"},{"key":"2025120523162485000_74.12.2035.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.02.004"},{"key":"2025120523162485000_74.12.2035.48","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00088-24","article-title":"Deacetylase Sirtuin 1 mitigates type I IFN- and type II IFN-induced signaling and antiviral immunity","volume":"98","author":"Yu","year":"2024","journal-title":"J Virol"},{"key":"2025120523162485000_74.12.2035.49","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202153955","article-title":"Cardio-respiratory and phenotypic rescue of dystrophin\/utrophin-deficient mice by combination therapy","volume":"23","author":"Lin","year":"2022","journal-title":"EMBO Rep"},{"key":"2025120523162485000_74.12.2035.50","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1716701","article-title":"Multifarious Beneficial Effect of Nonessential Amino Acid, Glycine: A Review","volume":"2017","author":"Razak","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"2025120523162485000_74.12.2035.51","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-330389"},{"key":"2025120523162485000_74.12.2035.52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.925741"},{"key":"2025120523162485000_74.12.2035.53","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-013-1493-1"},{"key":"2025120523162485000_74.12.2035.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104824"},{"key":"2025120523162485000_74.12.2035.55","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8613059"},{"key":"2025120523162485000_74.12.2035.56","doi-asserted-by":"publisher","DOI":"10.1038\/nm1096-1104"},{"key":"2025120523162485000_74.12.2035.57","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0241","article-title":"RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg","volume":"9","author":"Wooddell","year":"2017","journal-title":"Sci Transl Med"},{"key":"2025120523162485000_74.12.2035.58","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2482-5-18","article-title":"HEGPOL: randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312]","volume":"5","author":"Luntz","year":"2005","journal-title":"BMC Surg"},{"key":"2025120523162485000_74.12.2035.59","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.09.043"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2025-334813","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T07:16:37Z","timestamp":1765005397000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2025-334813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":59,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,11,10]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1136\/gutjnl-2025-334813"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2025-334813","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]}}}